In a study by Quist-Paulsen and colleagues, the cost of a nurse-led smoking intervention program compared favourably to other treatment modalities for CHD patients, being approximately 1/25 the cost of statins and angiotensin-converting enzyme inhibitors17. The gene discussed is ACE; the disease is coronary artery disorder.